Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Histogen Inc (HSTO)

Histogen Inc (HSTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Histogen Inc 10655 Sorrento Valley Road Suite 200 San Diego CA 92121 USA

www.histogen.com P: 858-526-3100

Description:

Histogen Inc. is a regenerative medicine company. It engages in developing patented technologies which replace and regenerates tissues in the body. The company's technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products. Histogen Inc., formerly known as Conatus Pharmaceuticals Inc., is based in San Diego, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,496
Enterprise Value, $K -11,014
Shares Outstanding, K 4,272
Annual Sales, $ 3,770 K
Annual Net Income, $ -10,620 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -3,860 K
EBIT, $ -12,060 K
EBITDA, $ -11,920 K
60-Month Beta 0.92
% of Insider Shareholders 3.30%
% of Institutional Shareholders 0.00%
Float, K 4,131
% Float 96.70%
Short Volume Ratio 0.95

Growth:

1-Year Return -61.54%
3-Year Return -98.49%
5-Year Return -99.81%
5-Year Revenue Growth -89.34%
5-Year Earnings Growth 97.16%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.90 on 11/09/23
Latest Earnings Date 05/09/24
Earnings Per Share ttm -2.81
EPS Growth vs. Prev Qtr -83.67%
EPS Growth vs. Prev Year 10.89%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 06/03/22

HSTO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -281.70%
Debt/Equity 0.00
Price/Sales 100.32
Price/Cash Flow N/A
Price/Book 0.34
Book Value/Share 1.03
Interest Coverage -0.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar